Book a regulatory artwork release sign-off package online. Compare vetted specialists who review and approve artwork files against labelling requirements before print release. Instant pricing.
✓ 3 active providers available right now· USD 330 – 411
Why this page is different
Instant pricing: See a price estimate immediately (no back-and-forth RFQ needed for these services).
Compare before booking: Review inclusions, exclusions, turnaround, and communication channels.
Charged only when accepted: You are charged only after a provider accepts your order and scope.
Live availability: 3 active providers available right now for this service.
What you can compare here
Total price: See live price ranges and instant pricing rules where available.
Coverage & scope: Markets served, what is included, and what is explicitly excluded.
SLA & responsiveness: Acceptance SLAs and typical turnaround windows.
Add-ons: Optional extras you can book next (shown as add-on chips).
Onboarding time: How quickly providers can start and what you need to supply.
Compare providers (instant pricing + book)
Provider
Estimated base price
Accept SLA
Turnaround
Start
Alpha Regulatory Partners
USD 360
24h
3–7 days
Within 2 business days
Beta Compliance Group
USD 411
24h
3–7 days
Within 2 business days
Gamma RegTech Solutions
USD 330
24h
3–7 days
Within 2 business days
Estimates are derived from each provider’s published pricing rules (and may vary by your inputs).
What affects pricing
These are the inputs providers use to price your order. Enter them once, then compare providers and book instantly.
skuCount(Required)
min 1
assetCount(Required)
min 1
markets(Required)
min 1
languages(Required)
min 1
layoutComplexity(Required)
simple|normal|complex
turnaround(Required)
standard|rush
desiredOutputs(Required)
min 1
uploads(Optional)
recommended; artwork PDFs/AI files
buyerNotes(Optional)
🖨️
Output
Approved artwork + sign-off record
🌍
Markets
EU · UK · US
⚡
Turnaround
1–5 business days
💰
Pricing
Per artwork file / per SKU
How it works
1
Upload your print-ready artwork file
Submit your final artwork (PDF, AI, INDD) and the approved content reference (previous approved label or regulatory dossier extract).
2
Compare artwork release specialists
View per-file fees from reviewers who conduct regulatory artwork comparisons and issue formal release records.
3
Receive your release approval and record
Your reviewer confirms artwork matches approved content, documents any deviations, and issues a formal artwork release sign-off record.
What is regulatory artwork release?
Regulatory artwork release is the formal approval process through which a print-ready label, packaging, or IFU artwork file is reviewed and signed off to confirm it accurately matches the approved regulatory content before going to print. In the medical device and pharmaceutical industries, this process is a critical quality gate: the approved content (the text, symbols, and design elements approved through your labelling change control process) must be exactly replicated in the artwork file that the printer will use to produce commercial packaging. Any discrepancy between the approved content dossier and the printed artwork — including minor typographic differences, symbol substitutions, or barcode encoding errors — is a labelling non-conformance.
What the artwork release check involves
A thorough artwork release review typically covers: (1) text comparison — every word of the print-ready artwork is compared against the approved label copy, character by character, to identify any discrepancies; (2) symbol verification — ISO 15223-1 symbols are checked for correct version and usage; (3) barcode quality — the barcode is verified for correct encoding (ensuring the human-readable value matches the machine-readable data) and is checked against print quality standards (ISO/IEC 15416 for linear barcodes, ISO/IEC 15415 for 2D DataMatrix); (4) UDI check — the UDI-DI and UDI-PI encoding and placement are verified against regulatory requirements; and (5) language versions — all language variants are checked against their respective approved translations.
Regulatory basis for formal artwork release
ISO 13485:2016 clause 7.3.4 requires that design and development outputs (which include labelling for medical devices) be approved before release, and that the approval be documented. FDA 21 CFR 820.30(d) similarly requires design outputs to be documented and expressed in terms that allow for verification against design inputs. A formal artwork release record — signed by a qualified reviewer, documenting the comparison methodology, the artwork version, and any deviations identified — provides the objective evidence that design output review was performed. During FDA inspections and notified body audits, inspectors routinely request artwork release records as evidence that labelling changes are controlled.
Common artwork release errors that cause problems
The most frequently identified artwork discrepancies in professional reviews include: incorrect allergen callouts that differ between the INCI list on file and the print artwork; missing mandatory EU MDR symbols (e.g., the "do not reuse" symbol absent on a single-use device); a DataMatrix barcode with a digit transposition that passes visual inspection but fails machine reading; an old logo or EC REP address from a superseded version of the label; wrong font size for mandatory regulatory text; and language version mix-ups where a French text page has been swapped with a German text page in a multi-lingual IFU booklet. All of these can be caught before print only with a systematic comparison process.
Frequently asked questions
What does a regulatory artwork release check?
An artwork release check compares the print-ready artwork to the approved label text and regulatory requirements — verifying text accuracy, symbol usage, barcodes, colour against specification, and print quality markers.
Is a formal artwork release required by regulation?
ISO 13485 clause 7.3.4 requires design outputs to be approved before release. For medical device labels, a formal artwork release record is considered best practice and is typically expected during FDA and notified body audits.
How Cruxi Bridge vets providers
✓ Every provider submits regulatory expertise evidence and jurisdictional coverage claims
✓ Providers that go live agree to the Cruxi Bridge Provider Terms including service delivery and accuracy obligations
✓ Payment is held by Cruxi and only released to the provider after service delivery milestones
✓ Buyers can raise a dispute within 30 days — Cruxi reviews and mediates per the platform terms
Prices and provider availability are live and may change. Charged only when a provider accepts your order.
← All services